Hemophilia: Marstacimab Sustains Long-Term Bleeding Decrease

Marstacimab shows long-term safety and efficacy in preventing bleeding events in patients with hemophilia A and B without inhibitors, potentially expanding treatment options.
MDedge News

source https://www.medscape.com/s/viewarticle/hemophilia-marstacimab-sustains-long-term-bleeding-decrease-2024a1000c2a?src=rss